Visiongain Report Offers Transformative Insights on $38bn Respiratory Inhalers Market

LONDON, October 25, 2018 /PRNewswire/ --

Dry Powder Inhalers, Single-dose DPI, Multi-dose DPI, Metered Dose Inhalers, Nebulizers, Jet Nebulizers, Ultrasonic Nebulizers, Vibrating-mesh Nebulizers, Asthma, COPD, Others 

The global respiratory inhalers market reached $33bn in 2017 and is estimated to reach $38bn by 2023. In 2017, the asthma segment held 58% of the global respiratory inhalers market.

     (Logo: https://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 165-page report you will receive 121 charts- all unavailable elsewhere.

The 165-page report provides clear detailed insight into the respiratory inhalers market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope 

• Global Respiratory Inhalers Market from 2018-2028

• Forecast of the Global Respiratory Inhalers market by Type of Product:
• Metered Dose Inhalers (MDIs)
• Dry Powder Inhalers (DPIs): Single-dose DPIs, Multi-dose DPIs
• Nebulizers: Jet Nebulizers, Ultrasonic Nebulizers, Vibrating-mesh Nebulizers

• Forecast of the Global Respiratory Inhalers market by Indication:
• Asthma
• COPD
• Other Respiratory Diseases

• This report provides individual revenue forecasts to 2028 for these national markets:
• The US
• Germany
• France
• UK
• Italy
• Spain
• Japan
• China
• India
• Russia
• Brazil
• Mexico
• Canada

• Our study discusses the selected leading companies that are the major players in the respiratory inhalers market:
• AstraZeneca
• Boehringer Ingelheim
• Chiesi Farmaceutici S.p.A.
• GlaxoSmithKline (GSK)
• Merck & Co.
• Novartis
• Teva

• This report discusses factors that drive and restrain this market. As well as opportunities and challenges faced by this market.

• This report discusses the Porter's Five Forces Analysis of the respiratory inhalers market.

Visiongain's study is intended for anyone requiring commercial analyses for the respiratory inhalers market. You find data, trends and predictions.

To request a report overview of this report please contact Sara Peerun at sara.peerun@visiongain.com or refer to our website: https://www.visiongain.com/report/the-global-respiratory-inhalers-market-2018-2028/

3M Drug Delivery Systems
Actavis
Adherium Limited
Aerogen
Agilent Technology
Airssential
Allied Healthcare
Almirall
Astrazeneca
Boehringer Ingelheim
Briggs Healthcare
CareFusion
Chiesi
Circassia Pharmaceuticals plc
Cipla
Clement Clarke International
Cohero Health
DeVilbiss Healthcare
Fexicare
Gecko Health Innovations
GF Health Products
GlaxoSmithKline
Heyer Medical
Hikma
IBM Watson Health
Innovate Biomed
Innoviva
Inspiro Medical
Mabis Healthcare
Medline Surgical
Merck
MRK Healthcare
Mylan
Nexus 6
Nouvag AG
Novartis
Omron Healthcare
Opko Health
Orion Pharma
PARI Medical
Pfizer
Philips Respironics
Propeller Health
Qualcomm Incorporated
Roche
Schering-Plough
Sunovion Pharma
Takeda Pharmaceutical Company Limited
Teva Pharmaceuticals
Theravance
Vectura
Viatris

List of Organizations Mentioned in the Report
British Lung Foundation
Centers for Disease Control and Prevention
Centre for Devices and Radiological Health
European Databank on Medical Devices
European Medicines Agency
European Respiratory Society
Food and Drug Administration
German Ministry of Health
Global Initiative for Asthma
Global Initiative for Chronic Obstructive Lung Disease
IBM Watson Health
Kaohsiung Medical University
Ministry of Health, Labour and Welfare
Mount Sinai Hospital
MRC Technology
ServicioSanitarioNazionale
UK NHS
US National Heart, Lung, and Blood Institute
US National Institutes of Health
Weill Cornell Medicine
World Health Organization (WHO)

To see a report overview please e-mail Sara Peerun on sara.peerun@visiongain.com